Language:

Breast cancer in pregnancy

The Lancet (British edition), 2012-02, Vol.379 (9815), p.570-579 [Peer Reviewed Journal]

Elsevier Ltd ;2012 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(11)61092-1 ;PMID: 22325662 ;CODEN: LANCAO

Full text available

Citations Cited by

Actions
1. Add to My Research
2. Remove from My Research
3. E-mail
4. Print
5. Permalink
6. Citation
7. EasyBib
8. EndNote
9. RefWorks
10. Delicious
11. Export RIS
12. Export BibTeX

Title:
Breast cancer in pregnancy
Author: Amant, Frédéric, Dr ; Loibl, Sibylle, MD ; Neven, Patrick, MD ; Van Calsteren, Kristel, MD
Subjects: Antineoplastic Agents - adverse effects ; Antineoplastic Agents - therapeutic use ; Biological and medical sciences ; breast neoplasms ; Breast Neoplasms - diagnosis ; Breast Neoplasms - therapy ; chemotherapy ; Child ; Child Development - drug effects ; Delivery, Obstetric ; Female ; General aspects ; Gynecology. Andrology. Obstetrics ; Humans ; Internal Medicine ; Mammary gland diseases ; Medical sciences ; patients ; Postnatal Care ; Pregnancy ; Pregnancy Complications, Neoplastic - diagnosis ; Pregnancy Complications, Neoplastic - therapy ; premature birth ; Prenatal Care ; Prognosis ; radiotherapy ; surgery ; tamoxifen ; Tumors
Is Part Of: The Lancet (British edition), 2012-02, Vol.379 (9815), p.570-579
Description: Breast cancer staging and treatment are possible during pregnancy, and should be defined in a multidisciplinary setting. Tumour biology, tumour stage, and gestational stage at diagnosis determine the appropriate approach. Surgery for breast cancer is possible during all trimesters of pregnancy. Radiotherapy is possible during pregnancy but, dependent on the fetal dose received, can result in poor fetal outcomes. The decision to give radiotherapy should be made on an individual basis. Evidence increasingly supports administration of chemotherapy from 14 weeks' gestation onwards. New breast cancer treatments might be applicable to pregnant patients, but tamoxifen and trastuzumab are contraindicated during pregnancy. Cancer treatment during pregnancy will decrease the need for early delivery and thus prematurity, which is a major concern in management of breast cancer in pregnancy.
Publisher: Kidlington: Elsevier Ltd
Language: English
Identifier: ISSN: 0140-6736
EISSN: 1474-547X
DOI: 10.1016/S0140-6736(11)61092-1
PMID: 22325662
CODEN: LANCAO
Source: ProQuest One Psychology
MEDLINE
ProQuest Central

Back to results list


INSPIRE LIBRARY - TON DUC THANG UNIVERSITY	(84-028) 37 755 057	Feedback
19 Nguyen Huu Tho St. Dist.7, HCM	thuvien@tdtu.edu.vn	Feedback

Breast cancer in pregnancy

Elsevier Ltd ;2012 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(11)61092-1 ;PMID: 22325662 ;CODEN: LANCAO

Searching Remote Databases, Please Wait